FDA could approve Truvada for its off-label use as an HIV prevention pill

    A decision by the Food and Drug Administration could make the costly drug, Truvada, the newest preventative treatment for HIV.

    Truvada is currently used to treat individuals already infected with the HIV virus. But it’s the drug’s “off-label” uses in HIV prevention that are being considered. A June decision from the FDA would allow the drug to be officially marketed as a preventative solution.

    Opponents are afraid that if misused, the drug could create a drug-resistant HIV strain, which would lead to more infections, said a delawareonline.com article.

    Want a digest of WHYY’s programs, events & stories? Sign up for our weekly newsletter.

    It will take 126,000 members this year for great news and programs to thrive. Help us get to 100% of the goal.